(株)カワチ薬品の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 小売業 | 2664/E03356 | CAWACHI LIMITED |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2018/10/05 | 日証協 | 257,523株 | +15.93% | 300,044株 | +84.2% | 317,105株 | +4.43% | 37,600株 | +717.75% |
2018/09/28 | 日証協 | 222,141株 | -3.16% | 162,890株 | -50.31% | 303,660株 | -3.1% | 4,598株 | -73.27% |
2018/09/21 | 日証協 | 229,395株 | -10.96% | 327,843株 | +105.32% | 313,362株 | -5.57% | 17,200株 | -23.15% |
2018/09/14 | 日証協 | 257,633株 | -2.74% | 159,672株 | +34.08% | 331,861株 | +1.06% | 22,382株 | -6.74% |
2018/09/07 | 日証協 | 264,903株 | +3.14% | 119,091株 | -34.64% | 328,380株 | +3.11% | 24,000株 | +46.34% |
2018/08/31 | 日証協 | 256,835株 | +3.57% | 182,200株 | +14.81% | 318,462株 | +3.54% | 16,400株 | -34.81% |
2018/08/24 | 日証協 | 247,992株 | -3.48% | 158,700株 | -9.76% | 307,562株 | -1.58% | 25,157株 | -10.89% |
2018/08/17 | 日証協 | 256,926株 | +2.4% | 175,865株 | +124.24% | 312,505株 | +1.73% | 28,232株 | +59.5% |
2018/08/10 | 日証協 | 250,913株 | +0.9% | 78,427株 | -65.75% | 307,205株 | +4.49% | 17,700株 | -76.02% |
2018/08/03 | 日証協 | 248,682株 | +16.16% | 228,952株 | +236.07% | 294,005株 | +13.95% | 73,800株 | +254.81% |
2018/07/27 | 日証協 | 214,082株 | -4.85% | 68,127株 | +56.22% | 258,005株 | -1.83% | 20,800株 | +3.48% |
2018/07/20 | 日証協 | 224,992株 | 0% | 43,611株 | 0% | 262,805株 | 0% | 20,100株 | 0% |
2018/07/13 | 日証協 | 216,092株 | +2.71% | 61,500株 | -74.3% | 250,605株 | +9.72% | 33,500株 | -39.53% |
2018/07/06 | 日証協 | 210,382株 | +7.22% | 239,262株 | +847.95% | 228,405株 | +19.52% | 55,400株 | +106.6% |
2018/06/29 | 日証協 | 196,222株 | -3.33% | 25,240株 | -58.21% | 191,105株 | -6.91% | 26,815株 | -5.91% |
2018/06/22 | 日証協 | 202,982株 | +27.6% | 60,400株 | +187.02% | 205,290株 | +10.14% | 28,500株 | +8.78% |
2018/06/15 | 日証協 | 159,082株 | -3.73% | 21,044株 | +47.16% | 186,390株 | +2.61% | 26,200株 | +74.62% |
2018/06/08 | 日証協 | 165,238株 | -14.27% | 14,300株 | -75.48% | 181,646株 | -8.33% | 15,004株 | -36.96% |
2018/06/01 | 日証協 | 192,738株 | -0.99% | 58,328株 | +1032.8% | 198,142株 | -8.99% | 23,800株 | +1245.39% |
※株式分割は考慮していませんのでご注意ください。
Page Top